1. Alexander DL, Flynn JE, Linkins LA (1995) Innovation, R&D Productivity, and Global Market Share in the Pharmaceutical Industry. Review of Industrial Organization 10: 197–207
2. Akaho E, Fuji M, Inoue K, Hosono K, Bernan P, Gudorf P, Huang XJ (1995) A Comparative Study of Pricing and Marketing of Drugs Acting on the Central Nervous System in the U.S., Japan, and Quebec, with a Search for Factors to Stimulate Research and Development Activities. Journal of Research in Pharmaceutical Economics 6(4): 29–55
3. Chabala JC (1998) Historical Overview of the Developing Field of Molecular Diversity. In: Gordon EM, Kerwin JF Jr. (Hrsg) Combinatorial Chemistry and Molecular Diversity in Drug Discovery. New York, S 3–16
4. DiMasi JA, Hansen RW, Grabowski HG (2002) The Price of Innovation: New Estimates of Drug Development Costs. Journal of Health Economics 22: 151–185
5. EFPIA European Federation of Pharmaceutical Industries and Associations (2002) The European Pharmaceutical Industry-Key Data. Brüssel